학술논문
0.19-mg fluocinolone acetonide intravitreal implant for diabetic macular edema: intraocular pressure-related effects over 36 months
Document Type
Article
Author
Roth, Daniel B.; Eichenbaum, David; Malik, Deepika; Radcliffe, Nathan M.; Cutino, Antonio; Small, Kent W.; Abdelsalam, Ahmed; Shakoor, Akbar; Moshiri, Ala; Barkmeier, Andrew; Tewari, Asheesh; Baker, Carl; Kiernan, Daniel; Rosberger, Daniel; Roth, Daniel; Eichenbaum, David; Malik, Deepika; Marcus, Dennis; Dehning, Doug; Reichel, Elias; Tilton, Elisha; Fu, Evelyn; Kokame, Gregg; Salehi-Had, Hani; Bhatt, Harit; Nielsen, Jared; Prensky, Jay; Lim, Jennifer; Adleberg, Jon; Beck, Joseph; Gunn, Joseph; Podhorzer, Joseph; Small, Kent; Kooragayala, Lakshmana; Freisberg, Lars; Schocket, Lisa; Berrocal, Maria; Worrall, Martin; Cassell, Michael; Singer, Michael; Tsipursky, Michael; Holekamp, Nancy; Weber, Pamela; Merrill, Pauline; Campochiaro, Peter; Dugel, Pravin; Khurana, Rahul; Apte, Rajendra; Rathod, Rajiv; Katz, Randy; Chace, Richard; Kwun, Robert; Grigorian, Ruben; Mansour, Sam; Chexal, Saradha; Madreperla, Steven; Gonzalez, Victor; Aldred, William
Source
Ophthalmology Retina; 20230101, Issue: Preprints
Subject
Language
ISSN
24687219; 24686530
Abstract
To evaluate effects of the 0.19-mg fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN®) on intraocular pressure (IOP) in patients with diabetic macular edema (DME).